Vertex Pharmaceuticals, Inc. (VRTX)
429.30
+1.65
(+0.39%)
USD |
NASDAQ |
May 07, 10:58
Vertex Pharmaceuticals SG&A Expense (TTM) : 1.357B for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.56B |
| Amgen, Inc. | 6.965B |
| Biogen, Inc. | 2.468B |
| Gilead Sciences, Inc. | 8.398B |
| Moderna, Inc. | 979.00M |